Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus
Article Abstract:
The safety and metabolic effects of high-dose immunosuppression were determined, followed by autologous nonmyeloablative hematopoietic stem cell transplantation (AHST) in newly diagnosed type 1 diabetes mellitus (DM). With AHST, beta cell function was found to be increased in all but 1 patient and induced prolonged insulin independence in the majority of the patients.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases
Article Abstract:
A study to ascertain the nonmalignant, nonhematologic clinical indications that could call for the use of blood-and bone marrow-derived stem cells is conducted. Results reveal that the use of stem cells ameliorated conditions in some autoimmune and cardiovascular diseases but called for further trials.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. Novel lupus therapies show promise
- Abstracts: Egg donation and human embryonic stem-cell research. Organ donation after cardiac death. One step forward, two steps back - will there ever be an AIDS vaccine?
- Abstracts: Medical treatment of peripheral arterial disease. Does the clinical examination predict lower extremity peripheral arterial disease?
- Abstracts: Report reviews secondhand smoke risks: Some scientists question risk level
- Abstracts: Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: A systematic review